Tailoring therapy to best suit ST-segment elevation myocardial infarction: searching for the right fit.
作者信息
Armstrong Paul W, Welsh Robert C
机构信息
Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alta.
出版信息
CMAJ. 2003 Oct 28;169(9):925-7.
Abstract
摘要
相似文献
1
Tailoring therapy to best suit ST-segment elevation myocardial infarction: searching for the right fit.
CMAJ. 2003 Oct 28;169(9):925-7.
2
Effectiveness and safety of percutaneous coronary intervention after fibrinolytic therapy for ST-segment elevation acute myocardial infarction.
Am J Cardiol. 2011 Apr 1;107(7):1001-9. doi: 10.1016/j.amjcard.2010.11.024. Epub 2011 Jan 20.
3
Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis.
Eur Heart J. 2010 Sep;31(17):2156-69. doi: 10.1093/eurheartj/ehq204. Epub 2010 Jul 2.
4
[Management of ST-elevation myocardial infarction in 2012].
Ann Cardiol Angeiol (Paris). 2012 Dec;61(6):447-52. doi: 10.1016/j.ancard.2012.09.016. Epub 2012 Oct 4.
5
Rescue percutaneous coronary interventions for failed fibrinolytic therapy in ST-segment elevation myocardial infarction: a population-based study.
Am Heart J. 2011 Apr;161(4):764-770.e1. doi: 10.1016/j.ahj.2010.12.016.
6
An early invasive strategy versus ischemia-guided management after fibrinolytic therapy for ST-segment elevation myocardial infarction: a meta-analysis of contemporary randomized controlled trials.
Am Heart J. 2008 Sep;156(3):564-572, 572.e1-2. doi: 10.1016/j.ahj.2008.04.024. Epub 2008 Jun 30.
7
Fibrinolytic and mechanical intervention trials in ST elevation acute myocardial infarction.
J Interv Cardiol. 2002 Aug;15(4):321-34. doi: 10.1111/j.1540-8183.2002.tb01113.x.
8
[The optimal time window for percutaneous coronary intervention in thrombolysis-treated ST-elevation myocardial infarction].
G Ital Cardiol (Rome). 2010 Sep;11(9):670-3.
9
Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.
Am J Cardiol. 2010 Jun 1;105(11):1528-34. doi: 10.1016/j.amjcard.2010.01.005. Epub 2010 Apr 14.
10
Comparison of the predictive value of ST segment elevation resolution at 90 and 180 min after start of streptokinase in acute myocardial infarction. A substudy of the hirudin for improvement of thrombolysis (HIT)-4 study.
Eur Heart J. 1999 Nov;20(21):1563-71. doi: 10.1053/euhj.1999.1664.
引用本文的文献
1
Delivery of primary percutaneous coronary intervention for the management of acute ST segment elevation myocardial infarction: summary of the Cardiac Care Network of Ontario Consensus Report.
Can J Cardiol. 2006 Mar 1;22(3):243-50. doi: 10.1016/s0828-282x(06)70904-7.
2
Who was S. Weir Mitchell?
CMAJ. 2004 Jan 20;170(2):175-6.
本文引用的文献
1
Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?
Am J Cardiol. 2003 Oct 1;92(7):824-6. doi: 10.1016/s0002-9149(03)00891-9.
2
A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction.
N Engl J Med. 2003 Aug 21;349(8):733-42. doi: 10.1056/NEJMoa025142.
3
Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial.
Circulation. 2003 Sep 9;108(10):1184-90. doi: 10.1161/01.CIR.0000087447.12918.85. Epub 2003 Aug 18.
4
Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2).
Am Heart J. 2003 Aug;146(2):234-41. doi: 10.1016/S0002-8703(03)00316-8.
5
Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction.
Circulation. 2003 Jul 15;108(2):135-42. doi: 10.1161/01.CIR.0000081659.72985.A8. Epub 2003 Jul 7.
6
Rising to the challenge: transforming the treatment of ST-segment elevation myocardial infarction.
CMAJ. 2003 Jul 8;169(1):35-7.
7
Primary angioplasty for ST-segment elevation myocardial infarction: ready for prime time?
CMAJ. 2003 Jul 8;169(1):32-5.
8
Outcome of primary angioplasty for acute myocardial infarction during routine duty hours versus during off-hours.
J Am Coll Cardiol. 2003 Jun 18;41(12):2138-42. doi: 10.1016/s0735-1097(03)00461-3.
9
Fibrinolytic therapy: is it a treatment of the past?
Circulation. 2003 May 27;107(20):2538-42. doi: 10.1161/01.CIR.0000075292.29458.BB.
10
Fibrinolysis for acute myocardial infarction: the future is here and now.
Circulation. 2003 May 27;107(20):2533-7. doi: 10.1161/01.CIR.0000072930.64775.DC.
Zotero 插件